Target intelligence / Profile preview

Filamentous actin barbed end (F-actin barbed end)

Target
F-actin barbed end
Molecular classification
Cytoskeletal protein, Protein polymer, Actin filament
01

Overview

The Filamentous actin (F-actin) barbed end, also known as the plus end, is the primary site of rapid actin monomer (G-actin) addition and filament growth within the cellular cytoskeleton. This dynamic structure is essential for generating the mechanical force required for cell motility, cytokinesis, and the maintenance of cell shape (Pollard & Borisy, 2003). Regulation of the barbed end is managed by a variety of endogenous proteins, including capping proteins like CapZ and severing proteins like gelsolin, which control filament length and stability (Edwards et al., 2014). In pathological states, such as cancer metastasis, the dysregulation of barbed end dynamics allows for uncontrolled cell migration and invasion (Yamaguchi & Condeelis, 2007). Furthermore, certain intracellular pathogens, such as Listeria monocytogenes, hijack barbed end assembly to move within and between host cells (Loisel et al., 1999). Pharmacological agents like cytochalasins specifically target the barbed end to inhibit polymerization, serving as powerful tools in cell biology research and potential templates for anti-metastatic or anti-pathogenic therapies, although their high systemic toxicity remains a significant therapeutic challenge (Cooper, 1987).

Other names
Plus endFast-growing endActin filament barbed endBarbed end
02

Mechanism of action

Capping of the barbed end to prevent the addition and dissociation of actin subunits, thereby inhibiting filament polymerization and dynamics.

03

Biological functions

Cell motilityCytokinesisEndocytosisCell shape maintenanceIntracellular transportForce generation
04

Disease associations

Cancer metastasisInfectious diseaseCardiovascular diseaseNeurodegenerative disease
05

Safety considerations

High systemic toxicity due to the ubiquitous nature of actinPotential for severe cardiac and skeletal muscle dysfunctionDisruption of essential cellular processes such as division and vesicle transportNarrow therapeutic index
06

Interacting drugs

Cytochalasin D

4 more in the full profile.

07

Biomarkers

F-actin to G-actin ratioCapZ expression levelsGelsolin concentrationPhalloidin staining intensity

Beyond the preview

Go deeper on Filamentous actin barbed end (F-actin barbed end).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Filamentous actin barbed end (F-actin barbed end).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call